{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:38Z","timestamp":1791576158366,"version":"4.3.4"},"reference-count":311,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P34341-B"],"award-info":[{"award-number":["P34341-B"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Bone and bone marrow are among the most frequent metastatic sites of cancer. The occurrence of bone metastasis is frequently associated with a dismal disease outcome. The prevention and therapy of bone metastases is a priority in the treatment of cancer patients. However, current therapeutic options for patients with bone metastatic disease are limited in efficacy and associated with increased morbidity. Therefore, most current therapies are mainly palliative in nature. A better understanding of the underlying molecular pathways of the bone metastatic process is warranted to develop novel, well-tolerated and more successful treatments for a significant improvement of patients\u2019 quality of life and disease outcome. In this review, we provide comparative mechanistic insights into the bone metastatic process of various solid tumors, including pediatric cancers. We also highlight current and innovative approaches to biologically targeted therapy and immunotherapy. In particular, we discuss the role of the bone marrow microenvironment in the attraction, homing, dormancy and outgrowth of metastatic tumor cells and the ensuing therapeutic implications. Multiple signaling pathways have been described to contribute to metastatic spread to the bone of specific cancer entities, with most knowledge derived from the study of breast and prostate cancer. However, it is likely that similar mechanisms are involved in different types of cancer, including multiple myeloma, primary bone sarcomas and neuroblastoma. The metastatic rate-limiting interaction of tumor cells with the various cellular and noncellular components of the bone-marrow niche provides attractive therapeutic targets, which are already partially exploited by novel promising immunotherapies.<\/jats:p>","DOI":"10.3390\/cells10112944","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T22:21:08Z","timestamp":1635805268000},"page":"2944","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Mechanisms, Diagnosis and Treatment of Bone Metastases"],"prefix":"10.3390","volume":"10","author":[{"given":"Jozef","family":"Ban","sequence":"first","affiliation":[{"name":"St. Anna Children\u2019s Cancer Research Institute, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Fock","sequence":"additional","affiliation":[{"name":"St. Anna Children\u2019s Cancer Research Institute, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave N. T.","family":"Aryee","sequence":"additional","affiliation":[{"name":"St. Anna Children\u2019s Cancer Research Institute, 1090 Vienna, Austria"},{"name":"Department of Pediatrics, Medical University Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6873-9109","authenticated-orcid":false,"given":"Heinrich","family":"Kovar","sequence":"additional","affiliation":[{"name":"St. Anna Children\u2019s Cancer Research Institute, 1090 Vienna, Austria"},{"name":"Department of Pediatrics, Medical University Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/cam4.2474","article-title":"Are 90% of deaths from cancer caused by metastases?","volume":"8","author":"Dillekas","year":"2019","journal-title":"Cancer Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: A fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100231","DOI":"10.1016\/j.jbo.2019.100231","article-title":"Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice","volume":"16","author":"Stamatopoulos","year":"2019","journal-title":"J. Bone Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.21037\/atm.2020.03.55","article-title":"Incidence of patients with bone metastases at diagnosis of solid tumors in adults: A large population-based study","volume":"8","author":"Huang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-08-1754","article-title":"Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence","volume":"15","author":"Morgan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tjensvoll, K., Oltedal, S., Heikkil\u00e4, R., Kval\u00f8y, J.T., Gilje, B., Reuben, J.M., Smaaland, R., and Nordg\u00e5rd, O. (2012). Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-190"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/scd.2020.0142","article-title":"Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications","volume":"30","author":"Hochheuser","year":"2021","journal-title":"Stem Cells Dev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1007\/s13277-014-1799-y","article-title":"Osteosarcoma metastasis: Prospective role of ezrin","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clgc.2016.07.027","article-title":"Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial","volume":"15","author":"Vogelzang","year":"2017","journal-title":"Clin. Genitourin Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.trecan.2015.07.009","article-title":"Surviving at a Distance: Organ-Specific Metastasis","volume":"1","author":"Obenauf","year":"2015","journal-title":"Trends Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40880-019-0425-1","article-title":"Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer","volume":"39","author":"Zhang","year":"2019","journal-title":"Cancer Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrc.2016.44","article-title":"Bone metastasis: The importance of the neighbourhood","volume":"16","author":"Croucher","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","first-page":"321","article-title":"Bone Metastases: An Overview","volume":"11","author":"Macedo","year":"2017","journal-title":"Oncol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1152\/physrev.00012.2019","article-title":"Bone metastasis: Mechanisms, therapies, and biomarkers","volume":"101","author":"Clezardin","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1228522","article-title":"Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition","volume":"339","author":"Yu","year":"2013","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: A hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nature20609","article-title":"Mechanism of early dissemination and metastasis in Her2(+) mammary cancer","volume":"540","author":"Harper","year":"2016","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc2627","article-title":"Parallel progression of primary tumours and metastases","volume":"9","author":"Klein","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1530\/ERC-14-0199","article-title":"Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone","volume":"21","author":"Ottewell","year":"2014","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: Molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"ref_22","first-page":"773","article-title":"Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2\u2032-deoxyuridine","volume":"45","author":"Fidler","year":"1970","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrc1886","article-title":"Metastasis: A question of life or death","volume":"6","author":"Mehlen","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2147\/CMAR.S168579","article-title":"The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer","volume":"10","author":"Guo","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/pcan.2011.7","article-title":"Mortality following bone metastasis and skeletal-related events among men with prostate cancer: A population-based analysis of US Medicare beneficiaries, 1999\u20132006","volume":"14","author":"Sathiakumar","year":"2011","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.cell.2021.03.011","article-title":"The bone microenvironment invigorates metastatic seeds for further dissemination","volume":"184","author":"Zhang","year":"2021","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/bonekey.2015.10","article-title":"Molecular alterations that drive breast cancer metastasis to bone","volume":"4","author":"Ottewell","year":"2015","journal-title":"Bonekey Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial-mesenchymal transitions","volume":"7","author":"Thiery","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jcp.1041500314","article-title":"Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines","volume":"150","author":"Thompson","year":"1992","journal-title":"J. Cell. Physiol."},{"key":"ref_33","first-page":"5190","article-title":"Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines","volume":"52","author":"Sommers","year":"1992","journal-title":"Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1242\/jcs.112.24.4615","article-title":"Vimentin contributes to human mammary epithelial cell migration","volume":"112 Pt. 24","author":"Gilles","year":"1999","journal-title":"J. Cell Sci"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1083\/jcb.147.3.631","article-title":"N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression","volume":"147","author":"Nieman","year":"1999","journal-title":"J. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1083\/jcb.148.4.779","article-title":"Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis","volume":"148","author":"Hazan","year":"2000","journal-title":"J. Cell Biol."},{"key":"ref_37","first-page":"3650","article-title":"Cadherin switching in human prostate cancer progression","volume":"60","author":"Tomita","year":"2000","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/pros.20334","article-title":"N-cadherin switching occurs in high Gleason grade prostate cancer","volume":"66","author":"Jaggi","year":"2006","journal-title":"Prostate"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/pros.20085","article-title":"Decreased stromal expression and increased epithelial expression of WFDC1\/ps20 in prostate cancer is associated with reduced recurrence-free survival","volume":"61","author":"McAlhany","year":"2004","journal-title":"Prostate"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1002\/ijc.22219","article-title":"Soluble N-cadherin in human biological fluids","volume":"119","author":"Derycke","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/jcb.20032","article-title":"Dual roles of E-cadherin in prostate cancer invasion","volume":"91","author":"Chunthapong","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1535-6108(03)00304-0","article-title":"Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion","volume":"4","author":"Lu","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cm.20095","article-title":"Rho family GTPases are activated during HGF-stimulated prostate cancer-cell scattering","volume":"62","author":"Wells","year":"2005","journal-title":"Cell Motil. Cytoskelet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1158\/0008-5472.CAN-05-3401","article-title":"N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1","volume":"66","author":"Alexander","year":"2006","journal-title":"Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1158\/0008-5472.CAN-04-3785","article-title":"Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target","volume":"65","author":"Kwok","year":"2005","journal-title":"Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1158\/0008-5472.CAN-06-3689","article-title":"Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells","volume":"67","author":"Gu","year":"2007","journal-title":"Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1677\/erc.1.00958","article-title":"Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells","volume":"12","author":"Lawrence","year":"2005","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1515\/BC.2006.089","article-title":"The role of kallikrein-related peptidases in prostate cancer: Potential involvement in an epithelial to mesenchymal transition","volume":"387","author":"Whitbread","year":"2006","journal-title":"Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1158\/0008-5472.CAN-05-0289","article-title":"Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells","volume":"65","author":"Yang","year":"2005","journal-title":"Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/pros.20488","article-title":"Prostate cancer metastasis: Role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis","volume":"66","author":"Xu","year":"2006","journal-title":"Prostate"},{"key":"ref_51","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jlb.66.1.25","article-title":"Adhesion and homing of blood-borne cells in bone marrow microvessels","volume":"66","author":"Mazo","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10555-007-9109-4","article-title":"The bone microenvironment in metastasis; what is special about bone?","volume":"27","author":"Bussard","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00109-015-1329-4","article-title":"Bone metastasis and the metastatic niche","volume":"93","author":"Ren","year":"2015","journal-title":"J. Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and Significance of the Pre-metastatic Niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2013.07.036","article-title":"Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma","volume":"154","author":"Zhang","year":"2013","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"Muller","year":"2001","journal-title":"Nature"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_59","first-page":"1832","article-title":"Use of the stromal cell-derived factor-1\/CXCR4 pathway in prostate cancer metastasis to bone","volume":"62","author":"Taichman","year":"2002","journal-title":"Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10555-006-9019-x","article-title":"The pivotal role of CXCL12 (SDF-1)\/CXCR4 axis in bone metastasis","volume":"25","author":"Wang","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s13277-013-1218-9","article-title":"High-level expression of CXCR4 in breast cancer is associated with early distant and bone metastases","volume":"35","author":"Hung","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jcb.21835","article-title":"Annexin II\/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer","volume":"105","author":"Shiozawa","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1158\/1541-7786.MCR-14-0118","article-title":"Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow","volume":"13","author":"Jung","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/ERC-13-0548","article-title":"RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization","volume":"21","author":"Chu","year":"2014","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.bone.2007.07.024","article-title":"The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer","volume":"41","author":"Woodward","year":"2007","journal-title":"Bone"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Casimiro, S., Mohammad, K.S., Pires, R., Tato-Costa, J., Alho, I., Teixeira, R., Carvalho, A., Ribeiro, S., Lipton, A., and Guise, T.A. (2013). RANKL\/RANK\/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063153"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature14492","article-title":"The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase","volume":"522","author":"Cox","year":"2015","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jbo.2016.04.002","article-title":"The role of microRNAs in bone metastasis","volume":"5","author":"Zoni","year":"2016","journal-title":"J. Bone Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ccr.2013.09.008","article-title":"Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis","volume":"24","author":"Ell","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1038\/sj.onc.1210429","article-title":"Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling","volume":"26","author":"McCabe","year":"2007","journal-title":"Oncogene"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/bcr1398","article-title":"Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone","volume":"8","author":"Sloan","year":"2006","journal-title":"Breast Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2018.03.050","article-title":"Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1\/integrin alpha4beta1 system","volume":"426","author":"Chang","year":"2018","journal-title":"Cancer Lett"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1038\/s41467-019-12807-0","article-title":"Microenvironmental IL1beta promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling","volume":"10","author":"Eyre","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"340ra373","DOI":"10.1126\/scitranslmed.aad4059","article-title":"Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone","volume":"8","author":"Price","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41556-019-0309-2","article-title":"Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis","volume":"21","author":"Esposito","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fonc.2020.00335","article-title":"The Endosteal Niche in Breast Cancer Bone Metastasis","volume":"10","author":"Haider","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e1156","DOI":"10.1002\/cnr2.1156","article-title":"Tumor dormancy in bone","volume":"3","author":"Mayhew","year":"2020","journal-title":"Cancer Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.neo.2015.11.005","article-title":"Breast Cancer Cell Colonization of the Human Bone Marrow Adipose Tissue Niche","volume":"17","author":"Templeton","year":"2015","journal-title":"Neoplasia"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ncb2767","article-title":"The perivascular niche regulates breast tumour dormancy","volume":"15","author":"Ghajar","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI43414","article-title":"Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow","volume":"121","author":"Shiozawa","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrclinonc.2016.144","article-title":"Circulating and disseminated tumour cells\u2014Mechanisms of immune surveillance and escape","volume":"14","author":"Mohme","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00223-017-0365-1","article-title":"Osteomimicry: How the Seed Grows in the Soil","volume":"102","author":"Rucci","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.critrevonc.2017.05.004","article-title":"Overcoming immunosuppression in bone metastases","volume":"117","author":"Reinstein","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"576269","DOI":"10.3389\/fmolb.2020.576269","article-title":"Pan-Cancer Analyses Reveal Prognostic Value of Osteomimicry Across 20 Solid Cancer Types","volume":"7","author":"Yang","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e10125","DOI":"10.1002\/jbm4.10125","article-title":"Tumor Cell Dormancy and Reactivation in Bone: Skeletal Biology and Therapeutic Opportunities","volume":"3","author":"Byrne","year":"2019","journal-title":"JBMR Plus"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","article-title":"The dormant cancer cell life cycle","volume":"20","author":"Phan","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Gomatou, G., Syrigos, N., Vathiotis, I.A., and Kotteas, E.A. (2021). Tumor Dormancy: Implications for Invasion and Metastasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094862"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1084\/jem.20110840","article-title":"Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone","volume":"208","author":"Kobayashi","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/ncb2861","article-title":"TGF-beta2 dictates disseminated tumour cell fate in target organs through TGF-beta-RIII and p38alpha\/beta signalling","volume":"15","author":"Bragado","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Kan, C., Vargas, G., Pape, F.L., and Cl\u00e9zardin, P. (2016). Cancer Cell Colonisation in the Bone Microenvironment. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17101674"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"36520","DOI":"10.1038\/srep36520","article-title":"Axl is required for TGF-\u03b22-induced dormancy of prostate cancer cells in the bone marrow","volume":"6","author":"Yumoto","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.trecan.2018.10.010","article-title":"TGF-\u03b2 Family Signaling Pathways in Cellular Dormancy","volume":"5","author":"Prunier","year":"2019","journal-title":"Trends Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7150\/ijbs.2929","article-title":"TGF-\u03b2 and BMP signaling in osteoblast differentiation and bone formation","volume":"8","author":"Chen","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Taichman, R.S., Patel, L.R., Bedenis, R., Wang, J., Weidner, S., Schumann, T., Yumoto, K., Berry, J.E., Shiozawa, Y., and Pienta, K.J. (2013). GAS6 receptor status is associated with dormancy and bone metastatic tumor formation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061873"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1158\/1541-7786.MCR-11-0569","article-title":"Hypoxia stabilizes GAS6\/Axl signaling in metastatic prostate cancer","volume":"10","author":"Mishra","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature13145","article-title":"Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone","volume":"507","author":"Kusumbe","year":"2014","journal-title":"Nature"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1158\/0008-5472.CAN-17-1051","article-title":"Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFbetaRIII-p38MAPK-pS249\/T252RB Pathway","volume":"78","author":"Yu","year":"2018","journal-title":"Cancer Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1084\/jem.20180661","article-title":"Wnt5a induces and maintains prostate cancer cells dormancy in bone","volume":"216","author":"Ren","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"ra63","DOI":"10.1126\/scisignal.2005231","article-title":"Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells","volume":"7","author":"Ono","year":"2014","journal-title":"Sci. Signal."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1158\/0008-5472.CAN-16-1092","article-title":"Mesenchymal Stem Cell-Derived Exosomes Stimulate Cycling Quiescence and Early Breast Cancer Dormancy in Bone Marrow","volume":"76","author":"Bliss","year":"2016","journal-title":"Cancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s43018-021-00179-8","article-title":"Bone marrow NG2+\/Nestin+ mesenchymal stem cells drive DTC dormancy via TGF-\u03b22","volume":"2","author":"Nobre","year":"2021","journal-title":"Nat. Cancer"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: Mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Shupp, A.B., Kolb, A.D., Mukhopadhyay, D., and Bussard, K.M. (2018). Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts. Cancers, 10.","DOI":"10.3390\/cancers10060182"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/ncomms9983","article-title":"Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche","volume":"6","author":"Lawson","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1158\/1078-0432.CCR-13-1246","article-title":"Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo","volume":"20","author":"Ottewell","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ijc.29439","article-title":"OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone","volume":"137","author":"Ottewell","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccr.2011.11.002","article-title":"VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitors","volume":"20","author":"Lu","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccell.2014.11.017","article-title":"The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells","volume":"27","author":"Wang","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fendo.2018.00339","article-title":"Bone Marrow Adipocyte: An Intimate Partner With Tumor Cells in Bone Metastasis","volume":"9","author":"Luo","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1158\/1078-0432.CCR-05-1806","article-title":"Kinetics of metastatic breast cancer cell trafficking in bone","volume":"12","author":"Phadke","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3816\/CBC.2007.s.001","article-title":"Biology of bone metastases: Causes and consequences","volume":"7","author":"Harvey","year":"2007","journal-title":"Clin. Breast Cancer"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","article-title":"Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets","volume":"60","author":"Liang","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis","volume":"98","author":"Guise","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1476-4598-13-42","article-title":"High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor","volume":"13","author":"Joeckel","year":"2014","journal-title":"Mol. Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1158\/0008-5472.CAN-15-2614","article-title":"Calcium-Sensing Receptor Promotes Breast Cancer by Stimulating Intracrine Actions of Parathyroid Hormone-Related Protein","volume":"76","author":"Kim","year":"2016","journal-title":"Cancer Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02591651","article-title":"Tissue-type plasminogen activator is involved in skeletal metastasis from human breast cancer","volume":"21","author":"Yamashita","year":"1992","journal-title":"Int. J. Clin. Lab. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1158\/1078-0432.306.11.1","article-title":"Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice","volume":"11","author":"Lev","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ccr.2009.05.017","article-title":"Latent bone metastasis in breast cancer tied to Src-dependent survival signals","volume":"16","author":"Zhang","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1038\/onc.2015.297","article-title":"Myeloid-specific TGF-\u03b2 signaling in bone promotes basic-FGF and breast cancer bone metastasis","volume":"35","author":"Meng","year":"2016","journal-title":"Oncogene"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1158\/0008-5472.CAN-09-4092","article-title":"Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation","volume":"70","author":"Coenegrachts","year":"2010","journal-title":"Cancer Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10585-008-9172-4","article-title":"Bone resorption increases tumour growth in a mouse model of osteosclerotic breast cancer metastasis","volume":"25","author":"Zheng","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/pros.21316","article-title":"Vitamin D deficiency promotes prostate cancer growth in bone","volume":"71","author":"Zheng","year":"2011","journal-title":"Prostate"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/0008-5472.CAN-09-3194","article-title":"Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis","volume":"70","author":"Ooi","year":"2010","journal-title":"Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10585-004-2869-0","article-title":"The effect of osteoprotegerin administration on the intra-tibial growth of the osteoblastic LuCaP 23.1 prostate cancer xenograft","volume":"21","author":"Kiefer","year":"2004","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_127","first-page":"295","article-title":"Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer","volume":"9","author":"Corey","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-04-2033","article-title":"Osteoprotegerin in prostate cancer bone metastasis","volume":"65","author":"Corey","year":"2005","journal-title":"Cancer Res."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Karlsson, T., Lundholm, M., Widmark, A., and Persson, E. (2016). Tumor Cell-Derived Exosomes from the Prostate Cancer Cell Line TRAMP-C1 Impair Osteoclast Formation and Differentiation. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166284"},{"key":"ref_130","first-page":"73","article-title":"Dkk-1 and IL-7 in plasma of patients with multiple myeloma prevent differentiation of mesenchymal stem cells into osteoblasts","volume":"4","author":"Nierste","year":"2014","journal-title":"Am. J. Blood Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00774-008-0012-z","article-title":"Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1alpha and MIP-1beta production","volume":"27","author":"Abe","year":"2009","journal-title":"J. Bone Miner. Metab."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrurol.2015.90","article-title":"Targeting bone metastases in prostate cancer: Improving clinical outcome","volume":"12","author":"Body","year":"2015","journal-title":"Nat. Rev. Urol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/jbmr.2300","article-title":"Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: Evidence from in vivo models","volume":"29","author":"Wang","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrc1528","article-title":"Osteoblasts in prostate cancer metastasis to bone","volume":"5","author":"Logothetis","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_135","first-page":"5652","article-title":"Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway","volume":"61","author":"Yang","year":"2001","journal-title":"Cancer Res."},{"key":"ref_136","first-page":"2587","article-title":"Prostate cancer cells-osteoblast interaction shifts expression of growth\/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts","volume":"9","author":"Fizazi","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","article-title":"Basic mechanisms responsible for osteolytic and osteoblastic bone metastases","volume":"12","author":"Guise","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jbo.2016.03.007","article-title":"The role of osteoblasts in bone metastasis","volume":"5","author":"Ottewell","year":"2016","journal-title":"J. Bone Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1210\/me.2006-0346","article-title":"Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation","volume":"21","author":"Clines","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10735-012-9415-1","article-title":"Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiation","volume":"43","author":"Itoh","year":"2012","journal-title":"J. Mol. Histol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1073\/pnas.1717363115","article-title":"Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A","volume":"115","author":"Hashimoto","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"94834","DOI":"10.18632\/oncotarget.22014","article-title":"Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer","volume":"8","author":"Ye","year":"2017","journal-title":"Oncotarget"},{"key":"ref_144","first-page":"135","article-title":"Prostate cancer cell survival pathways activated by bone metastasis microenvironment","volume":"5","author":"Tenta","year":"2005","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"ref_145","first-page":"917","article-title":"Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer","volume":"62","author":"Yi","year":"2002","journal-title":"Cancer Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2028s","DOI":"10.1093\/jn\/125.suppl_7.2028S","article-title":"Endothelin receptors, second messengers, and actions in bone","volume":"125","author":"Stern","year":"1995","journal-title":"J. Nutr."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1074\/jbc.M114.621219","article-title":"Wnt\/\u03b2-catenin signaling mediates osteoblast differentiation triggered by peptide-induced \u03b15\u03b21 integrin priming in mesenchymal skeletal cells","volume":"290","author":"Saidak","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"42575","DOI":"10.1074\/jbc.M111.294595","article-title":"Regulation of breast cancer-induced bone lesions by \u03b2-catenin protein signaling","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/ijc.23625","article-title":"Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: Implication for breast cancer osteolytic bone metastases","volume":"123","author":"Bu","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e2015","DOI":"10.1038\/cddis.2015.367","article-title":"P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development","volume":"7","author":"Velletri","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.gene.2018.01.093","article-title":"Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures","volume":"650","author":"Tian","year":"2018","journal-title":"Gene"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/path.2603","article-title":"Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2","volume":"219","author":"Mohseny","year":"2009","journal-title":"J. Pathol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/1878-0261.12189","article-title":"Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition","volume":"12","author":"Pietrovito","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41419-019-1532-2","article-title":"Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.18632\/oncotarget.3211","article-title":"Extracellular vesicles from bone marrow mesenchymal stem\/stromal cells transport tumor regulatory microRNA, proteins, and metabolites","volume":"6","author":"Vallabhaneni","year":"2015","journal-title":"Oncotarget"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ijc.30540","article-title":"Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-\u03baB activation","volume":"140","author":"Avnet","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/stem.1298","article-title":"Transforming growth factor \u03b21 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma","volume":"31","author":"Zhang","year":"2013","journal-title":"Stem Cells"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"24171","DOI":"10.1074\/jbc.M604507200","article-title":"Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression","volume":"281","author":"McMahon","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3727\/096504016X14562725373752","article-title":"MicroRNA-20b Downregulates HIF-1\u03b1 and Inhibits the Proliferation and Invasion of Osteosarcoma Cells","volume":"23","author":"Liu","year":"2016","journal-title":"Oncol. Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3727\/096504016X14743337535446","article-title":"MicroRNA-33b Inhibits the Proliferation and Migration of Osteosarcoma Cells via Targeting Hypoxia-Inducible Factor-1\u03b1","volume":"25","author":"Zhou","year":"2017","journal-title":"Oncol. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s13277-013-1223-z","article-title":"Oxymatrine induces mitochondria dependent apoptosis in human osteosarcoma MNNG\/HOS cells through inhibition of PI3K\/Akt pathway","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/jcb.26387","article-title":"ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K\/AKT pathways","volume":"119","author":"Huang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3892\/or.2014.3358","article-title":"Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK\/ERK pathway","volume":"32","author":"Miao","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/tox.22548","article-title":"Delphinidin induces apoptosis and inhibits epithelial-to-mesenchymal transition via the ERK\/p38 MAPK-signaling pathway in human osteosarcoma cell lines","volume":"33","author":"Kang","year":"2018","journal-title":"Environ. Toxicol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/cancers7020784","article-title":"Hedgehog signaling inhibitors as anti-cancer agents in osteosarcoma","volume":"7","author":"Kumar","year":"2015","journal-title":"Cancers"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1038\/onc.2013.433","article-title":"Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression","volume":"33","author":"Chan","year":"2014","journal-title":"Oncogene"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1078-0432.CCR-17-0692","article-title":"Degalactotigonin, a Natural Compound from Solanum nigrum L., Inhibits Growth and Metastasis of Osteosarcoma through GSK3\u03b2 Inactivation-Mediated Repression of the Hedgehog\/Gli1 Pathway","volume":"24","author":"Zhao","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41422-020-0370-1","article-title":"Wnt signaling and Loxl2 promote aggressive osteosarcoma","volume":"30","author":"Matsuoka","year":"2020","journal-title":"Cell Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fphar.2017.00285","article-title":"FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases","volume":"8","author":"Gustafson","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1002\/jcb.26011","article-title":"Wnt\/\u03b2-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types","volume":"118","author":"Vega","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/jor.24244","article-title":"Bone morphogenetic protein-2 promotes osteosarcoma growth by promoting epithelial-mesenchymal transition (EMT) through the Wnt\/\u03b2-catenin signaling pathway","volume":"37","author":"Tian","year":"2019","journal-title":"J. Orthop. Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1158\/1078-0432.CCR-09-2261","article-title":"Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing\u2019s sarcoma","volume":"16","author":"Erkizan","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1038\/onc.2017.202","article-title":"EWS-FLI1 perturbs MRTFB\/YAP-1\/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma","volume":"36","author":"Katschnig","year":"2017","journal-title":"Oncogene"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.orthres.2003.12.008","article-title":"Targeting of EWS\/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing\u2019s sarcoma cells in vitro","volume":"22","author":"Chansky","year":"2004","journal-title":"J. Orthop. Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1038\/onc.2016.498","article-title":"Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation\/migration choices in Ewing sarcoma cells","volume":"36","author":"Franzetti","year":"2017","journal-title":"Oncogene"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ccell.2021.05.007","article-title":"STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma","volume":"39","author":"Adane","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ccell.2021.04.001","article-title":"STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma","volume":"39","author":"Surdez","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41389-020-00294-8","article-title":"YAP\/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells","volume":"10","author":"Bierbaumer","year":"2021","journal-title":"Oncogenesis"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1158\/0008-5472.CAN-07-6145","article-title":"EWS-FLI1 suppresses NOTCH-activated p53 in Ewing\u2019s sarcoma","volume":"68","author":"Ban","year":"2008","journal-title":"Cancer Res."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Zhang, H.F., Hughes, C.S., Li, W., He, J.Z., Surdez, D., El-Naggar, A.M., Cheng, H., Prudova, A., Delaidelli, A., and Negri, G.L. (2021). Proteomic screens for suppressors of anoikis identify IL1RAP as a promising surface target in Ewing sarcoma. Cancer Discov.","DOI":"10.1158\/2159-8290.CD-20-1690"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Lissat, A., Joerschke, M., Shinde, D.A., Braunschweig, T., Meier, A., Makowska, A., Bortnick, R., Henneke, P., Herget, G., and Gorr, T.A. (2015). IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1564-7"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0360-3016(03)00418-8","article-title":"Ewing\u2019s sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-alpha (TNF-alpha) after radiation exposure","volume":"56","author":"Wilfert","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/boc.201200086","article-title":"First identification of Ewing\u2019s sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications","volume":"105","author":"Miller","year":"2013","journal-title":"Biol. Cell"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.7150\/thno.13944","article-title":"Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model","volume":"6","author":"Villasante","year":"2016","journal-title":"Theranostics"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jcb.22782","article-title":"The Ewing\u2019s sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation","volume":"111","author":"Li","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevEukarGeneExpr.v10.i2.50","article-title":"Molecular mechanisms of tumor-bone interactions in osteolytic metastases","volume":"10","author":"Chirgwin","year":"2000","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fonc.2015.00279","article-title":"Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma","volume":"5","author":"Redini","year":"2015","journal-title":"Front. Oncol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3343\/alm.2018.38.2.132","article-title":"Clinical and Cytogenetic Profiles of Rhabdomyosarcoma with Bone Marrow Involvement in Korean Children: A 15-Year Single-Institution Experience","volume":"38","author":"Lee","year":"2018","journal-title":"Ann. Lab. Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"100834","DOI":"10.1016\/j.ajoc.2020.100834","article-title":"Bone metastasis of retinoblastoma five years after primary treatment","volume":"19","author":"Ting","year":"2020","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/j.1460-2075.1991.tb08052.x","article-title":"N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma","volume":"10","author":"Bernards","year":"1991","journal-title":"EMBO J."},{"key":"ref_191","first-page":"2012","article-title":"N-myc down regulates neural cell adhesion molecule expression in rat neuroblastoma","volume":"10","author":"Akeson","year":"1990","journal-title":"Mol. Cell. Biol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1158\/0008-5472.CAN-12-2681","article-title":"Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis","volume":"73","author":"Teitz","year":"2013","journal-title":"Cancer Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/carcin\/bgi192","article-title":"The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness","volume":"26","author":"Hecht","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Muhlethaler-Mottet, A., Liberman, J., Ascencao, K., Flahaut, M., Balmas Bourloud, K., Yan, P., Jauquier, N., Gross, N., and Joseph, J.M. (2015). The CXCR4\/CXCR7\/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125616"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fphar.2018.00500","article-title":"Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis","volume":"9","author":"Ulrich","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00262-007-0392-2","article-title":"CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow","volume":"57","author":"Airoldi","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2008.07.029","article-title":"The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells","volume":"273","author":"Nevo","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1158\/0008-5472.CAN-11-2165","article-title":"A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma","volume":"72","author":"Silverman","year":"2012","journal-title":"Cancer Res."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Shankar, V., Hori, H., Kihira, K., Lei, Q., Toyoda, H., Iwamoto, S., and Komada, Y. (2015). Mesenchymal stromal cell secretome up-regulates 47 kDa CXCR4 expression, and induce invasiveness in neuroblastoma cell lines. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120069"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1774144","DOI":"10.1080\/20013078.2020.1774144","article-title":"Neuroblastoma-secreted exosomes carrying miR-375 promote osteogenic differentiation of bone-marrow mesenchymal stromal cells","volume":"9","author":"Colletti","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Hochheuser, C., van Zogchel, L.M.J., Kleijer, M., Kuijk, C., Tol, S., van der Schoot, C.E., Voermans, C., Tytgat, G.A.M., and Timmerman, I. (2020). The Metastatic Bone Marrow Niche in Neuroblastoma: Altered Phenotype and Function of Mesenchymal Stromal Cells. Cancers, 12.","DOI":"10.3390\/cancers12113231"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"e1574198","DOI":"10.1080\/2162402X.2019.1574198","article-title":"Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cells","volume":"8","author":"Morandi","year":"2019","journal-title":"Oncoimmunology"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Morandi, F., Scaruffi, P., Gallo, F., Stigliani, S., Moretti, S., Bonassi, S., Gambini, C., Mazzocco, K., Fardin, P., and Haupt, R. (2012). Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0029922"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.otsr.2016.11.001","article-title":"Metastatic fractures of long limb bones","volume":"103","author":"Anract","year":"2017","journal-title":"Orthop. Traumatol. Surg. Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/107327481702400206","article-title":"Skeletal Scintigraphy","volume":"24","author":"Makanji","year":"2017","journal-title":"Cancer Control"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"303","DOI":"10.23736\/S1824-4785.16.02830-2","article-title":"Half-time bone scintigraphy in prostate and breast cancer patients","volume":"62","author":"Grootjans","year":"2018","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/iju.13386","article-title":"Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer","volume":"24","author":"Nakajima","year":"2017","journal-title":"Int. J. Urol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejrad.2005.01.019","article-title":"Whole-body MR imaging of bone marrow","volume":"55","author":"Schmidt","year":"2005","journal-title":"Eur. J. Radiol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/RLI.0000000000000579","article-title":"Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging","volume":"54","author":"Arita","year":"2019","journal-title":"Investig. Radiol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cpet.2018.05.004","article-title":"(18)F-Sodium Fluoride PET\/CT and PET\/MR Imaging of Bone and Joint Disorders","volume":"13","author":"Beheshti","year":"2018","journal-title":"PET Clin."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/MNM.0000000000001051","article-title":"Comparison of 18F-Fluciclovine PET\/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer","volume":"40","author":"Chen","year":"2019","journal-title":"Nucl. Med. Commun."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/jjco\/29.1.16","article-title":"Biochemical markers of bone turnover in breast cancer patients with bone metastases: A preliminary report","volume":"29","author":"Shimozuma","year":"1999","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ecl.2017.04.003","article-title":"Biochemical Testing Relevant to Bone","volume":"46","author":"Chew","year":"2017","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1302\/0301-620X.102B3.BJJ-2019-0976.R1","article-title":"Surgery for femoral metastases","volume":"102-B","author":"Tanaka","year":"2020","journal-title":"Bone Jt. J."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.21037\/apm.2018.12.04","article-title":"Palliation of bone metastases-exploring options beyond radiotherapy","volume":"8","author":"David","year":"2019","journal-title":"Ann. Palliat. Med."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1385\/MO:20:3:203","article-title":"Vertebroplasty for metastasis","volume":"20","author":"Wenger","year":"2003","journal-title":"Med. Oncol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/09553002.2020.1729441","article-title":"Comparative studies on the potential use of (177)Lu-based radiopharmaceuticals for the palliative therapy of bone metastases","volume":"96","author":"Zakaly","year":"2020","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.urology.2014.11.031","article-title":"Radium-223 dichloride for metastatic castration-resistant prostate cancer: The urologist\u2019s perspective","volume":"85","author":"Shore","year":"2015","journal-title":"Urology"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1213755","article-title":"Alpha emitter radium-223 and survival in metastatic prostate cancer","volume":"369","author":"Parker","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1200\/JCO.2017.75.3657","article-title":"Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial","volume":"36","author":"Kyriakopoulos","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2217\/nnm-2017-0190","article-title":"Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain","volume":"12","author":"Gdowski","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000502655","article-title":"Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer","volume":"103","author":"Miyoshi","year":"2019","journal-title":"Urol. Int."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/ctrv.1999.0137","article-title":"Current options in treatment of anthracycline-resistant breast cancer","volume":"25","author":"Achterrath","year":"1999","journal-title":"Cancer Treat. Rev."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.12659\/MSM.905300","article-title":"Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes","volume":"23","author":"Wang","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jjco\/hyp145","article-title":"Capecitabine monotherapy is efficient and safe in all line settings in patients with metastatic and advanced breast cancer","volume":"40","author":"Amari","year":"2010","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2018.11.027","article-title":"Survival and prognosis with osteosarcoma: Outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort","volume":"109","author":"Smeland","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"863210","DOI":"10.1155\/2011\/863210","article-title":"Current therapeutic approaches in metastatic and recurrent ewing sarcoma","volume":"2011","author":"Huang","year":"2011","journal-title":"Sarcoma"},{"key":"ref_228","first-page":"173","article-title":"Metastatic Ewing\u2019s Sarcoma: Revisiting the \u201cEvidence on the Fence\u201d","volume":"38","author":"Khanna","year":"2017","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/CCO.0b013e3281214400","article-title":"Management of painful bone metastases","volume":"19","author":"Mercadante","year":"2007","journal-title":"Curr. Opin. Oncol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"12174","DOI":"10.1038\/s41598-019-48634-y","article-title":"Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations","volume":"9","author":"Nanni","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1002\/ijc.29217","article-title":"Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours","volume":"136","author":"Braekeveldt","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"9750795","DOI":"10.1155\/2016\/9750795","article-title":"Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX","volume":"2016","author":"Rea","year":"2016","journal-title":"BioMed Res. Int."},{"key":"ref_233","first-page":"1987","article-title":"Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone","volume":"59","author":"Nemeth","year":"1999","journal-title":"Cancer Res."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3171\/spi.2006.4.5.388","article-title":"A novel human osteoblast-derived severe combined immunodeficiency mouse model of bone metastasis","volume":"4","author":"Schuster","year":"2006","journal-title":"J. Neurosurg. Spine"},{"key":"ref_235","first-page":"3935","article-title":"Role of tumor-derived exosomes in bone metastasis","volume":"18","author":"Li","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncb3408","article-title":"Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow","volume":"18","author":"Johnson","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"75571","DOI":"10.18632\/oncotarget.12289","article-title":"IL-1 drives breast cancer growth and bone metastasis in vivo","volume":"7","author":"Holen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/ijc.32554","article-title":"GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer","volume":"146","author":"Sawada","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41388-019-0977-1","article-title":"Notch3 promotes prostate cancer-induced bone lesion development via MMP-3","volume":"39","author":"Ganguly","year":"2020","journal-title":"Oncogene"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41585-018-0020-2","article-title":"Translational models of prostate cancer bone metastasis","volume":"15","author":"Berish","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"100205","DOI":"10.1016\/j.jbo.2018.10.004","article-title":"Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management","volume":"15","author":"Coleman","year":"2019","journal-title":"J. Bone Oncol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/14656566.2020.1717468","article-title":"Combination and sequential treatment in women with postmenopausal osteoporosis","volume":"21","author":"Anastasilakis","year":"2020","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Marocco, C., Zimatore, G., Mocini, E., Fornari, R., Iolascon, G., Gallotta, M.C., Bimonte, V.M., Baldari, C., Lenzi, A., and Migliaccio, S. (2021). Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18041728"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.12659\/MSM.913236","article-title":"Addition of Zoledronate to Chemotherapy in Patients with Osteosarcoma Treated with Limb-Sparing Surgery: A Phase III Clinical Trial","volume":"25","author":"Li","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"11523","DOI":"10.1200\/JCO.2020.38.15_suppl.11523","article-title":"Efficacy of maintenance therapy with zoledronic acid in patients with localized Ewing sarcoma: Report from the international Ewing 2008 trial","volume":"38","author":"Dirksen","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/15384101.2017.1288326","article-title":"The importance of regulatory ubiquitination in cancer and metastasis","volume":"16","author":"Gallo","year":"2017","journal-title":"Cell Cycle"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","article-title":"The role of ubiquitination and deubiquitination in cancer metabolism","volume":"19","author":"Sun","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Toscani, D., Craviotto, L., and Giuliani, N. (2021). The Role of Proteasome Inhibitors in Multiple Myeloma Bone Disease and Bone Metastasis: Effects on Osteoblasts and Osteocytes. Appl. Sci., 11.","DOI":"10.3390\/app11104642"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1172\/JCI16198","article-title":"Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro","volume":"111","author":"Garrett","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood-2006-11-059188","article-title":"The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients","volume":"110","author":"Giuliani","year":"2007","journal-title":"Blood"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"9428","DOI":"10.1111\/jcmm.15605","article-title":"Cell cycle exit during bortezomib-induced osteogenic differentiation of mesenchymal stem cells was mediated by Xbp1s-upregulated p21(Cip1) and p27(Kip1)","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s13287-020-02037-3","article-title":"ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation","volume":"11","author":"Zhang","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1158\/1078-0432.CCR-09-3293","article-title":"A proteasome inhibitor, bortezomib, inhibits breast cancer growth and reduces osteolysis by downregulating metastatic genes","volume":"16","author":"Jones","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3892\/ijo.2014.2545","article-title":"Bortezomib prevents oncogenesis and bone metastasis of prostate cancer by inhibiting WWP1, Smurf1 and Smurf2","volume":"45","author":"Wang","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"115492","DOI":"10.1016\/j.bone.2020.115492","article-title":"Targeting anti-cancer agents to bone using bisphosphonates","volume":"138","author":"Xing","year":"2020","journal-title":"Bone"},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Russow, G., Jahn, D., Appelt, J., Mardian, S., Tsitsilonis, S., and Keller, J. (2018). Anabolic Therapies in Osteoporosis and Bone Regeneration. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20010083"},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Rothe, R., Hauser, S., Neuber, C., Laube, M., Schulze, S., Rammelt, S., and Pietzsch, J. (2020). Adjuvant Drug-Assisted Bone Healing: Advances and Challenges in Drug Delivery Approaches. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12050428"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1038\/s41467-019-12108-6","article-title":"The CXCL5\/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis","volume":"10","author":"Curtis","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_259","first-page":"e60367","article-title":"Establishment and Analysis of Three-Dimensional (3D) Organoids Derived from Patient Prostate Cancer Bone Metastasis Specimens and their Xenografts","volume":"156","author":"Lee","year":"2020","journal-title":"J. Vis. Exp."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"e1702787","DOI":"10.1002\/smll.201702787","article-title":"A Spontaneous 3D Bone-On-a-Chip for Bone Metastasis Study of Breast Cancer Cells","volume":"14","author":"Hao","year":"2018","journal-title":"Small"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"e1900924","DOI":"10.1002\/adhm.201900924","article-title":"Engineering a Novel 3D Printed Vascularized Tissue Model for Investigating Breast Cancer Metastasis to Bone","volume":"9","author":"Cui","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nano.2015.09.010","article-title":"3D printed nanocomposite matrix for the study of breast cancer bone metastasis","volume":"12","author":"Zhu","year":"2016","journal-title":"Nanomedicine"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1039\/D0BM00921K","article-title":"A 3D printed in vitro bone model for the assessment of molecular and cellular cues in metastatic neuroblastoma","volume":"9","author":"Aveic","year":"2021","journal-title":"Biomater. Sci."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.pharmthera.2013.05.005","article-title":"Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs","volume":"139","author":"Yang","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(15)00613-0","article-title":"Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): Final analysis of the multicentre, double-blind, phase 3 randomised controlled trial","volume":"17","author":"Cristofanilli","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1200\/JCO.2016.69.2871","article-title":"Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial","volume":"35","author":"Smith","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Hao, Y., Baker, D., and Ten Dijke, P. (2019). TGF-\u03b2-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112767"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/bonekey.2012.96","article-title":"The role of TGF-\u03b2 in bone metastasis: Novel therapeutic perspectives","volume":"1","author":"Buijs","year":"2012","journal-title":"Bonekey Rep."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1158\/0008-5472.CAN-05-3565","article-title":"Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor","volume":"66","author":"Bandyopadhyay","year":"2006","journal-title":"Cancer Res."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1101\/gad.1824809","article-title":"ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis","volume":"23","author":"Lu","year":"2009","journal-title":"Genes Dev."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1038\/s41388-020-01481-y","article-title":"Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2","volume":"39","author":"Wang","year":"2020","journal-title":"Oncogene"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ncb3513","article-title":"The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer","volume":"19","author":"Krebs","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41467-017-01197-w","article-title":"miR-1199-5p and Zeb1 function in a double-negative feedback loop potentially coordinating EMT and tumour metastasis","volume":"8","author":"Diepenbruck","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Muz, B., Abdelghafer, A., Markovic, M., Yavner, J., Melam, A., Salama, N.N., and Azab, A.K. (2021). Targeting E-selectin to Tackle Cancer Using Uproleselan. Cancers, 13.","DOI":"10.3390\/cancers13020335"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pharmthera.2013.10.006","article-title":"Targeting tumor-stromal interactions in bone metastasis","volume":"141","author":"Esposito","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1593\/tlo.12268","article-title":"CXCR4 Expression and Treatment with SDF-1\u03b1 or Plerixafor Modulate Proliferation and Chemosensitivity of Colon Cancer Cells","volume":"6","author":"Heckmann","year":"2013","journal-title":"Transl. Oncol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1593\/neo.91384","article-title":"GAS6\/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche","volume":"12","author":"Shiozawa","year":"2010","journal-title":"Neoplasia"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1158\/0008-5472.CAN-07-2661","article-title":"AXL is a potential target for therapeutic intervention in breast cancer progression","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13058-019-1117-0","article-title":"Osteoblasts are \u201ceducated\u201d by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment","volume":"21","author":"Kolb","year":"2019","journal-title":"Breast Cancer Res."},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Xiang, L., and Gilkes, D.M. (2019). The Contribution of the Immune System in Bone Metastasis Pathogenesis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040999"},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Kahkonen, T.E., Halleen, J.M., and Bernoulli, J. (2021). Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis. Cells, 10.","DOI":"10.3390\/cells10061529"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: Evolving concepts in bone-immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nrrheum.2017.213","article-title":"Updating osteoimmunology: Regulation of bone cells by innate and adaptive immunity","volume":"14","author":"Walsh","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_284","doi-asserted-by":"crossref","unstructured":"Mendoza-Reinoso, V., McCauley, L.K., and Fournier, P.G.J. (2020). Contribution of Macrophages and T Cells in Skeletal Metastasis. Cancers, 12.","DOI":"10.3390\/cancers12041014"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3389\/fphar.2019.01255","article-title":"Targeting Macrophages: Friends or Foes in Disease?","volume":"10","author":"Ardura","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.4049\/jimmunol.1101855","article-title":"Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells","volume":"189","author":"Sawant","year":"2012","journal-title":"J. Immunol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1159\/000489184","article-title":"Molecular Regulation of Bone Metastasis Pathogenesis","volume":"46","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4161\/onci.1.2.18480","article-title":"Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer","volume":"1","author":"Zhao","year":"2012","journal-title":"Oncoimmunology"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fimmu.2015.00605","article-title":"Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity","volume":"6","author":"Dahlberg","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"205796","DOI":"10.1155\/2014\/205796","article-title":"Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer","volume":"2014","author":"Romee","year":"2014","journal-title":"Scientifica"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.20141836","article-title":"CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages","volume":"212","author":"Kitamura","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.molmed.2018.03.006","article-title":"Macrophages: The Road Less Traveled, Changing Anticancer Therapy","volume":"24","author":"Guerriero","year":"2018","journal-title":"Trends Mol. Med."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2016.11.029","article-title":"The involvement of M2 macrophage polarization inhibition in fenretinide-mediated chemopreventive effects on colon cancer","volume":"388","author":"Dong","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.intimp.2010.07.002","article-title":"The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE(2) in murine macrophages","volume":"10","author":"Edwards","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"e954460","DOI":"10.4161\/21624011.2014.954460","article-title":"Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity","volume":"3","author":"Muller","year":"2014","journal-title":"Oncoimmunology"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/1574892812666170606123113","article-title":"Immune Cells Act as Promising Targets for the Treatment of Bone Metastasis","volume":"12","author":"Luo","year":"2017","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/rccm.201405-0992OC","article-title":"CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease","volume":"191","author":"Rennard","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1158\/0008-5472.CAN-15-0054","article-title":"IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment","volume":"75","author":"Benevides","year":"2015","journal-title":"Cancer Res."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1038\/s41467-020-20138-8","article-title":"Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells","volume":"11","author":"Nguyen","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.cell.2019.10.029","article-title":"Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy","volume":"179","author":"Jiao","year":"2019","journal-title":"Cell"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s40425-018-0417-8","article-title":"Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: A seminal case series","volume":"6","author":"Moseley","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/annonc\/mdx643","article-title":"Nivolumab-associated bone marrow necrosis","volume":"29","author":"Hilal","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13058-017-0927-1","article-title":"Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model","volume":"20","author":"Pillai","year":"2018","journal-title":"Breast Cancer Res."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3389\/fonc.2020.01012","article-title":"Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity","volume":"10","author":"Patel","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_308","doi-asserted-by":"crossref","unstructured":"Karkampouna, S., De Filippo, M.R., Ng, C.K.Y., Klima, I., Zoni, E., Spahn, M., Stein, F., Haberkant, P., Thalmann, G.N., and Kruithof-de Julio, M. (2020). Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures. Cancers, 12.","DOI":"10.1101\/2020.04.03.018143"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13058-019-1220-2","article-title":"Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts","volume":"21","author":"Lefley","year":"2019","journal-title":"Breast Cancer Res."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"100254","DOI":"10.1016\/j.cobme.2020.100254","article-title":"Nanostructured Biomaterials for In Vitro Models of Bone Metastasis Cancer","volume":"17","author":"Katti","year":"2021","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"ref_311","doi-asserted-by":"crossref","unstructured":"Hughes, A.M., Kolb, A.D., Shupp, A.B., Shine, K.M., and Bussard, K.M. (2021). Printing the Pathway Forward in Bone Metastatic Cancer Research: Applications of 3D Engineered Models and Bioprinted Scaffolds to Recapitulate the Bone-Tumor Niche. Cancers, 13.","DOI":"10.3390\/cancers13030507"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/11\/2944\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:22:35Z","timestamp":1760167355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/11\/2944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":311,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["cells10112944"],"URL":"https:\/\/doi.org\/10.3390\/cells10112944","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]}}}